AMHERST After researching two local jails, Baystate Medical Center and the University of Massachusetts Amherst researchers have published a new study that found a substantial reduction in recidivism when a jail offers those with opioid use disorder.
A study conducted in two rural Massachusetts jails found that people with opioid use disorder who were incarcerated and received a medication approved to treat opioid use disorder, known as buprenorphine, were less likely to face rearrest and reconviction after release than those who did not receive the medication.